The Medicines and Healthcare products Regulatory Agency announced on 24 September 2026 that five people had been appointed as commissioners of the Commission on Human Medicines for four years from 21 September 2026: Dr Andrew Hitchings, Dr Nigel Beckett, Dr Wajid Hussain, Professor Elvira Bramon and Professor Sarah Danson. The commission provides independent expert advice to ministers on the safety, quality and efficacy of medicines and promotes the collection and investigation of information on adverse reactions. It is an advisory non-departmental public body sponsored by the Department of Health and Social Care.

Several commissioners were also reappointed as of that announcement. Professor Anthony Williams, Professor David Dockrell, Professor David Hunt, Dr Geraldine Mortimore and Julia Cons were reappointed for four years from 1 July 2026, while Professor Paul Dargan and Professor Heather Wallace each received two-year reappointments, from 1 July and 1 September 2026 respectively. Professor David Moore's four-year reappointment was set to begin on 15 December 2026.

The roles were expected to involve about 22 days a year, including 11 meetings and possible ad-hoc meetings, with remuneration of £325 per meeting. The agency said the appointments followed the Cabinet Office Code of Governance for Public Appointments, were made on merit, and that none of the appointees had declared political activity.